Magdalena Sustkova-Fiserova
Overview
Explore the profile of Magdalena Sustkova-Fiserova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lapka M, Charalambous C, Khryakova A, Certilina A, Novotny J, Hejnova L, et al.
Pharmacol Biochem Behav
. 2023 Mar;
224:173528.
PMID: 36870422
Central ghrelin signaling seems to play important role in addiction as well as memory processing. Antagonism of the growth hormone secretagogue receptor (GHS-R1A) has been recently proposed as a promising...
2.
Sustkova-Fiserova M, Charalambous C, Khryakova A, Certilina A, Lapka M, Slamberova R
Int J Mol Sci
. 2022 Jan;
23(2).
PMID: 35054944
Drug addiction causes constant serious health, social, and economic burden within the human society. The current drug dependence pharmacotherapies, particularly relapse prevention, remain limited, unsatisfactory, unreliable for opioids and tobacco,...
3.
Charalambous C, Havlickova T, Lapka M, Puskina N, Slamberova R, Kuchar M, et al.
Int J Mol Sci
. 2021 Mar;
22(5).
PMID: 33673659
Cannabis/cannabinoids are widely used for recreational and therapy purposes, but their risks are largely disregarded. However, cannabinoid-associated use disorders and dependence are alarmingly increasing and an effective treatment is lacking....
4.
Charalambous C, Lapka M, Havlickova T, Syslova K, Sustkova-Fiserova M
Int J Mol Sci
. 2020 Dec;
22(1).
PMID: 33379212
The endocannabinoid/CB1R system as well as the central ghrelin signalling with its growth hormone secretagogoue receptors (GHS-R1A) are importantly involved in food intake and reward/reinforcement processing and show distinct overlaps...
5.
Sustkova-Fiserova M, Puskina N, Havlickova T, Lapka M, Syslova K, Pohorala V, et al.
Addict Biol
. 2019 Nov;
25(6):e12845.
PMID: 31696597
The extended occurrence of fentanils abuse associated with the dramatic increase in opioid fatal overdoses and dependence strongly emphasizes insufficiencies in opioid addiction treatment. Recently, the growth hormone secretagogue receptor...
6.
Havlickova T, Charalambous C, Lapka M, Puskina N, Jerabek P, Sustkova-Fiserova M
Int J Mol Sci
. 2018 Sep;
19(10).
PMID: 30261633
Methamphetamine abuse imposes a significant burden on individuals and society worldwide, and an effective therapy of methamphetamine addiction would provide distinguished social benefits. Ghrelin significantly participates in reinforcing neurobiological mechanisms...
7.
Sustkova-Fiserova M, Charalambous C, Havlickova T, Lapka M, Jerabek P, Puskina N, et al.
Int J Mol Sci
. 2017 Nov;
18(11).
PMID: 29165386
The opioid-induced rise of extracellular dopamine, endocannabinoid anandamide and γ-aminobutyric acid (GABA) concentrations triggered by opioids in the nucleus accumbens shell (NACSh) most likely participate in opioid reward. We have...
8.
Jerabek P, Havlickova T, Puskina N, Charalambous C, Lapka M, Kacer P, et al.
Neurochem Int
. 2017 Sep;
110:101-113.
PMID: 28958601
An increasing number of studies over the past few years have demonstrated ghrelin's role in alcohol, cocaine and nicotine abuse. However, the role of ghrelin in opioid effects has rarely...
9.
Sustkova-Fiserova M, Stolerman I
Psychopharmacology (Berl)
. 2016 Oct;
234(1):1-2.
PMID: 27761587
No abstract available.
10.
Sustkova-Fiserova M, Jerabek P, Havlickova T, Syslova K, Kacer P
Psychopharmacology (Berl)
. 2015 Oct;
233(3):469-84.
PMID: 26507196
Rationale And Objectives: In addition to dopamine, endocannabinoids are thought to participate in neural reward mechanisms of opioids. Number of recent studies suggests crucial involvement of ghrelin in some addictive...